Looks like it was extermely shorted. As per shortsqueeze.com:
MGRM $ 1.96
Monogram Biosciences Inc. -0.17
Shares Short 12,049,100
Days to Cover (Short Ratio) 22.4
Short % of Float 9.22 %
Shares Short - Prior 12,191,900
Short % Increase / Decrease -1.17 %
Squeeze Ranking™ 74
% from 52-Wk HIGH ( 2.70 ) -37.76 %
% from 52-Wk LOW ( 1.30 ) 33.67 %
% from 200-Day MA ( 1.81 ) 7.65 %
% from 50-Day MA ( 1.90 )
3.06 %
Price % Change (52-Wk) 35.70 %
Trading Volume - Today 4,788,666
Trading Volume - Average 538,000
Trading Volume Vs. Avg. 890.09 %
Total Shares - Float 130,650,000
Total Shares - Outstanding 131,742,353
% Held by Insiders 9.76 %
% Held by Institutions 53.60 %
Market Cap 258,215,017
EPS -0.30
PE Ratio
Sector: Healthcare
Industry: Diagnostic Substances
SI Record Date 2007-Apr
Information Provided Without Warranty
MGRM $ 1.96
Monogram Biosciences Inc. -0.17
Shares Short 12,049,100
Days to Cover (Short Ratio) 22.4
Short % of Float 9.22 %
Shares Short - Prior 12,191,900
Short % Increase / Decrease -1.17 %
Squeeze Ranking™ 74
% from 52-Wk HIGH ( 2.70 ) -37.76 %
% from 52-Wk LOW ( 1.30 ) 33.67 %
% from 200-Day MA ( 1.81 ) 7.65 %
% from 50-Day MA ( 1.90 )
3.06 %
Price % Change (52-Wk) 35.70 %
Trading Volume - Today 4,788,666
Trading Volume - Average 538,000
Trading Volume Vs. Avg. 890.09 %
Total Shares - Float 130,650,000
Total Shares - Outstanding 131,742,353
% Held by Insiders 9.76 %
% Held by Institutions 53.60 %
Market Cap 258,215,017
EPS -0.30
PE Ratio
Sector: Healthcare
Industry: Diagnostic Substances
SI Record Date 2007-Apr
Information Provided Without Warranty
Recent MGRM News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/15/2025 01:59:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/15/2025 01:58:09 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/15/2025 01:57:01 AM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 10/07/2025 09:02:29 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 10/07/2025 09:00:25 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 10/07/2025 08:59:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/07/2025 08:50:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/07/2025 08:49:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/07/2025 08:48:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/07/2025 08:37:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/30/2025 09:15:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/30/2025 09:05:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/30/2025 09:04:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/30/2025 09:03:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/30/2025 09:02:33 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/12/2025 07:16:11 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/05/2025 11:58:22 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2025 11:58:03 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/29/2025 07:50:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2025 07:49:06 PM
- Form DEFM14A - Definitive proxy statement relating to merger or acquisition • Edgar (US Regulatory) • 08/28/2025 07:22:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/15/2025 08:17:00 PM
- Form PREM14A - Preliminary proxy statements relating to merger or acquisition • Edgar (US Regulatory) • 08/11/2025 09:28:17 PM
- Zimmer Biomet Announces Second Quarter 2025 Financial Results • PR Newswire (US) • 08/07/2025 10:30:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 07/31/2025 11:10:29 AM
